142 related articles for article (PubMed ID: 8947841)
1. Identification of intermediates in the conversion of cholesterol to pregnenolone with a reconstituted cytochrome p-450scc system: accumulation of the intermediate modulated by the adrenodoxin level.
Sugano S; Miura R; Morishima N
J Biochem; 1996 Oct; 120(4):780-7. PubMed ID: 8947841
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol side-chain cleavage by mitochondria from the human placenta. Studies using hydroxycholesterols as substrates.
Tuckey RC
J Steroid Biochem Mol Biol; 1992 Sep; 42(8):883-90. PubMed ID: 1525048
[TBL] [Abstract][Full Text] [Related]
3. Catalytic properties of cytochrome P-450scc purified from the human placenta: comparison to bovine cytochrome P-450scc.
Tuckey RC; Cameron KJ
Biochim Biophys Acta; 1993 May; 1163(2):185-94. PubMed ID: 8490050
[TBL] [Abstract][Full Text] [Related]
4. Human placental cholesterol side-chain cleavage: enzymatic synthesis of (22R)-20 alpha,22-dihydroxycholesterol.
Tuckey RC; Cameron KJ
Steroids; 1993 May; 58(5):230-3. PubMed ID: 8356576
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P-450scc-catalyzed production of progesterone from 22R-hydroxycholest-4-en-3-one by way of 20,22-dihydroxycholest-4-en-3-one.
Sugano S; Morishima N; Horie S
J Steroid Biochem Mol Biol; 1990 Sep; 37(1):47-55. PubMed ID: 2242352
[TBL] [Abstract][Full Text] [Related]
6. The effect of glycerol on cytochrome P450scc (CYP11A1) spin state, activity, and hydration.
Headlam MJ; Tuckey RC
Arch Biochem Biophys; 2002 Nov; 407(1):95-102. PubMed ID: 12392719
[TBL] [Abstract][Full Text] [Related]
7. Evidence That Compound I Is the Active Species in Both the Hydroxylase and Lyase Steps by Which P450scc Converts Cholesterol to Pregnenolone: EPR/ENDOR/Cryoreduction/Annealing Studies.
Davydov R; Strushkevich N; Smil D; Yantsevich A; Gilep A; Usanov S; Hoffman BM
Biochemistry; 2015 Dec; 54(48):7089-97. PubMed ID: 26603348
[TBL] [Abstract][Full Text] [Related]
8. Electron paramagnetic resonance study of ferrous cytochrome P-450scc-nitric oxide complexes: effects of 20(R),22(R)-dihydroxycholesterol and reduced adrenodoxin.
Tsubaki M; Hiwatashi A; Ichikawa Y; Fujimoto Y; Ikekawa N; Hori H
Biochemistry; 1988 Jun; 27(13):4856-62. PubMed ID: 2844242
[TBL] [Abstract][Full Text] [Related]
9. Adrenodoxin with a COOH-terminal deletion (des 116-128) exhibits enhanced activity.
Cupp JR; Vickery LE
J Biol Chem; 1989 Jan; 264(3):1602-7. PubMed ID: 2912975
[TBL] [Abstract][Full Text] [Related]
10. The multistep oxidation of cholesterol to pregnenolone by human cytochrome P450 11A1 is highly processive.
McCarty KD; Liu L; Tateishi Y; Wapshott-Stehli HL; Guengerich FP
J Biol Chem; 2024 Jan; 300(1):105495. PubMed ID: 38006947
[TBL] [Abstract][Full Text] [Related]
11. Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies.
Davydov R; Gilep AA; Strushkevich NV; Usanov SA; Hoffman BM
J Am Chem Soc; 2012 Oct; 134(41):17149-56. PubMed ID: 23039857
[TBL] [Abstract][Full Text] [Related]
12. Analysis of In Vivo Activity of the Bovine Cholesterol Hydroxylase/Lyase System Proteins Expressed in Escherichia coli.
Efimova VS; Isaeva LV; Rubtsov MA; Novikova LA
Mol Biotechnol; 2019 Apr; 61(4):261-273. PubMed ID: 30729436
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric study of the enzymatic conversion of cholesterol to (22R)-22-hydroxycholesterol, (20R,22R)-20,22-dihydroxycholesterol, and pregnenolone, and of (22R)-22-hydroxycholesterol to the lgycol and pregnenolone in bovine adrenocortical preparations. Mode of oxygen incorporation.
Burstein S; Middleditch BS; Gut M
J Biol Chem; 1975 Dec; 250(23):9028-37. PubMed ID: 1238395
[TBL] [Abstract][Full Text] [Related]
14. Exclusion of 20(22)-dehydrocholesterol as an intermediate in the biosynthesis of pregnenolone in bovine adrenocortical mitochondrial acetone-dried powder preparations.
Burstein S; Byon CY; Kimball HL; Gut M
Steroids; 1976 May; 27(5):691-701. PubMed ID: 941186
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P-450 of adrenal mitochondria. Spin states as detected by difference spectroscopy.
Jefcoate CR
J Biol Chem; 1975 Jun; 250(12):4663-70. PubMed ID: 167000
[TBL] [Abstract][Full Text] [Related]
16. Creation and activity of COS-1 cells stably expressing the F2 fusion of the human cholesterol side-chain cleavage enzyme system.
Huang MC; Miller WL
Endocrinology; 2001 Jun; 142(6):2569-76. PubMed ID: 11356706
[TBL] [Abstract][Full Text] [Related]
17. Side-chain specificities of human and bovine cytochromes P-450scc.
Tuckey RC; Cameron KJ
Eur J Biochem; 1993 Oct; 217(1):209-15. PubMed ID: 8223556
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids enhance the cholesterol side-chain cleavage activity of ovine adrenocortical mitochondria.
Picard-Hagen N; Darbeida H; Durand P
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):57-65. PubMed ID: 7577721
[TBL] [Abstract][Full Text] [Related]
19. Isotope-Labeling Studies Support the Electrophilic Compound I Iron Active Species, FeO(3+), for the Carbon-Carbon Bond Cleavage Reaction of the Cholesterol Side-Chain Cleavage Enzyme, Cytochrome P450 11A1.
Yoshimoto FK; Jung IJ; Goyal S; Gonzalez E; Guengerich FP
J Am Chem Soc; 2016 Sep; 138(37):12124-41. PubMed ID: 27571509
[TBL] [Abstract][Full Text] [Related]
20. The catalytic cycle of cytochrome P-450scc and intermediates in the conversion of cholesterol to pregnenolone.
Hume R; Kelly RW; Taylor PL; Boyd GS
Eur J Biochem; 1984 May; 140(3):583-91. PubMed ID: 6723652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
